The CHIERS Act of 2026 authorizes federal grants to help individuals with substance use disorders reach treatment and supportive services by covering transportation costs. Eligible recipients include nonprofit organizations, government agencies, and health centers that will use the funds to provide rides, purchase vehicles, or pay for taxi services for these individuals. The program specifically targets people experiencing homelessness or living in low-income areas where travel barriers limit access to care, while explicitly excluding involuntary treatment transport and law enforcement use. To ensure effectiveness, grant recipients must submit detailed plans and performance reports focused on reducing missed appointments, and the funding is designed to supplement rather than replace existing local resources.
This resolution designates May 2026 as American Stroke Month to raise public awareness about stroke prevention and care. It encourages individuals to learn the B.E.F.A.S.T. warning signs, understand their personal risk factors, and take steps to improve community health outcomes. The bill does not change laws or allocate funding but serves as a symbolic expression of support for stroke education and recovery efforts.
This Senate resolution designates April 29, 2026, as National Fentanyl Awareness Day to highlight the dangers of fake or counterfeit pills containing lethal doses of fentanyl. The bill aims to increase public awareness among families and young people about how drug traffickers exploit the opioid crisis by selling dangerous counterfeit pills that mimic legitimate prescription medications. By supporting this day, the Senate encourages law enforcement efforts to combat the spread of these illicit drugs and urges the public to recognize the severe risks associated with counterfeit pills found across all states.
This bill requires the Department of Veterans Affairs to share a veteran's history of opioid prescriptions with their community healthcare providers. The rule applies to veterans receiving care outside the VA system and mandates that this prescription data be sent to both the specific non-VA doctors treating them and any third-party administrators managing their care. By updating existing regulations, the legislation aims to improve coordination between VA medical records and private healthcare providers to ensure comprehensive treatment information is available.
The Pregnant Women in Custody Act establishes new federal standards to protect the health and rights of pregnant women held in Bureau of Prisons facilities, immigration detention centers, and refugee shelters. It mandates comprehensive medical care, including mandatory pregnancy testing, access to contraception, and specialized dietary and housing accommodations tailored to pregnancy needs. A central provision prohibits the use of restrictive housing and physical restraints during pregnancy, labor, and the postpartum recovery period, with limited exceptions only for immediate safety threats. The legislation also requires facilities to provide nursery programs allowing mothers and infants to remain together, offers education on parental rights, and mandates regular reporting on health outcomes and the use of restrictive measures.
The Saving Lives on Campuses Act of 2026 requires public colleges and universities receiving federal funding to provide opioid overdose rescue kits across their campuses. These kits, which contain naloxone or similar FDA-approved medications, must be placed in classrooms, libraries, dormitories, and other student facilities, often near automated external defibrillators. Institutions are also tasked with registering kit locations, replacing expired supplies, and training new students on how to find and use them. The law aims to increase access to life-saving treatment for opioid overdoses by ensuring these medical supplies are readily available in high-traffic campus areas.
This bill directs the Department of Health and Human Services to study how domestic violence, sexual assault, and related traumas affect maternal health risks, including suicide, overdose, and poor birth outcomes, with a focus on diverse communities. It authorizes $15 million over three years to fund grants for states, healthcare providers, and community organizations to develop culturally relevant programs that support victims of violence during pregnancy and after childbirth. The legislation also requires the department to issue guidance within two years on how healthcare providers should routinely screen for intimate partner violence and implement trauma-informed care plans.
The "Workforce Recovery and Resilience Act" amends current law to address the workforce and economic impacts of substance use disorders. It requires the Department of Labor to provide states and local areas with information on effective practices for tackling these impacts, including how to access relevant funding. The bill also expands the use of national dislocated worker grants to fund employment and training activities related to substance use disorder prevention and treatment in areas heavily affected by addiction. Eligible individuals for these specific grants include dislocated workers, the long-term unemployed, those impacted by widespread substance use, and individuals in healthcare professions focused on substance use treatment.
The Nitazene Response Act directs the Department of Health and Human Services to create and publish clinical guidelines for treating nitazene overdoses, a specific type of ultra-potent synthetic opioid. These guidelines will outline best practices for administering naloxone and provide instructions for emergency departments, hospitals, and rural emergency medical services. The Secretary must publish the guidelines online within 180 days of the bill's enactment and submit a report to Congress within one year detailing how the guidelines address nitazene overdose risks. The legislation defines nitazene to include various benzimidazole-opioids such as etonitazene and isotonitazene, ensuring the guidelines cover this growing class of substances.
HR 5919, the Veterans HOPE Act, requires the Department of Veterans Affairs (VA) to conduct a comprehensive review of veteran deaths from opioid overdoses occurring between 2010 and 2016. The review must analyze demographic data (age, sex, race), medication histories (including black box warnings), prescribing patterns, combat trauma, and VA facility trends. Within 18 months of enactment, the VA must submit a public report to Congress detailing findings and recommendations to improve veteran safety and reduce opioid overdose rates. This procedural bill focuses on data collection and analysis, not new programs or funding.
